Abiopharma

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viking Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities

Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1b Trial of APG777 in Patients with Mild-to-Moderate Asthma and 2026 Anticipated Milestones on January 6, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neurocrine Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression

Ecolab Inc. - Ecolab Schedules Webcast and Conference Call on February 10, 2026

Ecolab Schedules Webcast and Conference Call on February 10, 2026